Form D · Pharmaceuticals

Plexiform Bioscience Inc.

Dover, DE · CIK 0002048968

Offering snapshot reported Jul 18, 2025 · SEC filing

Reported sold
$1.34M
Offering amount: $2.2M
Investors reported
14
Form D · investor count
Minimum accepted
$50K
Reported outside-investor minimum
First sale
Dec 3, 2024
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$670K$1.34MDec 17, 2024: $250,000.00Dec 17, 2024Jul 18, 2025: $1,340,000.00Jul 18, 2025

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$250,000 → $1,340,000
  • Reported investors4 → 14

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 18, 2025Amendment$1,340,000$1,090,000vs Dec 17, 202414SEC filing
Dec 17, 2024Initial$250,000No comparison4SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-532304

Source: Form D, filed Jul 18, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Saad Ahmad Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
8 The Green No 19634
Dover, DE, 19901
Phone: 7085137860